Charles Schwab Investment Management Inc Relay Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 912,157 shares of RLAY stock, worth $5.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

912,157

Previous 877,813 3.91%

Holding current value

$5.9 Million

Previous $9.66 Million 21.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$7.5 - $12.07 $257,580 - $414,532	34,344 Added 3.91%	912,157 $7.57 Million
Q4 2023 Feb 06, 2024	BUY	$6.01 - $11.48 $979,678 - $1.87 Million	163,008 Added 22.8%	877,813 $9.66 Million
Q3 2023 Nov 08, 2023	BUY	$8.24 - $12.97 $349,466 - $550,070	42,411 Added 6.31%	714,805 $6.01 Million
Q2 2023 Aug 09, 2023	BUY	$9.99 - $18.27 $184,934 - $338,214	18,512 Added 2.83%	672,394 $8.45 Million
Q1 2023 May 11, 2023	SELL	$15.0 - $22.76 $8,415 - $12,768	-561 Reduced 0.09%	653,882 $10.8 Million

Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $502,340 - $852,133	35,476 Added 5.73%	654,443 $9.78 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $1.33 Million - $2.31 Million	73,483 Added 13.47%	618,967 $13.8 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $11,899 - $31,182	894 Added 0.16%	545,484 $9.14 Million
Q1 2022 May 13, 2022	BUY	$20.26 - $32.36 $335,748 - $536,269	16,572 Added 3.14%	544,590 $16.3 Million
Q4 2021 Feb 11, 2022	BUY	$26.0 - $37.03 $2.59 Million - $3.69 Million	99,696 Added 23.28%	528,018 $16.2 Million
Q3 2021 Nov 16, 2021	BUY	$29.75 - $37.99 $6.11 Million - $7.8 Million	205,352 Added 92.1%	428,322 $13.5 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $791,422 - $1.1 Million	28,779 Added 14.82%	222,970 $8.16 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $1.13 Million - $2.13 Million	34,628 Added 21.7%	194,191 $6.71 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $160,505 - $244,215	4,520 Added 2.92%	159,563 $6.63 Million
Q3 2020 Nov 13, 2020	BUY	$32.81 - $45.1 $5.09 Million - $6.99 Million	155,043 New	155,043 $6.6 Million

Others Institutions Holding RLAY

# of Institutions

188

Shares Held

127M

Call Options Held

4.2K

Put Options Held

1.7K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $778M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Relay Therapeutics, Inc. Transaction History